Influenza vaccine use to protect healthy children

A debated topic

Nicola Principi, Susanna Esposito

Research output: Contribution to journalArticle

Abstract

At the beginning of this century, a number of studies suggested that in healthy children, particularly those <2. years of age, influenza could have a serious and complicated course, as it frequently led to hospitalization and sometimes, albeit rarely, to death. Moreover, pre-schoolers and school-age children were found to be among the most important causes of influenza transmission to the community, as they shed the virus for a longer time than adults and had frequent contact with greater numbers of individuals through day-care and school. These findings led a number of health authorities to modify the official recommendations regarding the use of influenza vaccine in healthy children. Several factors seem to indicate that vaccination against influenza in healthy children of any age and in pregnant women could be effective in preventing the disease in the entire paediatric population and in providing herd immunity in adults and old people as well. The direct advantages of the vaccine seem greater in younger subjects, particularly those <2-3. years of age. Vaccination of older children is considered effective by most experts, but high vaccination coverage of these subjects has been difficult to attain. Similar difficulties have been identified for the vaccination of pregnant women. These challenges can be overcome, at least in part, by appropriate information and accurate evaluations of available data. In addition, further studies specifically designed to clarify unresolved problems regarding vaccine use in paediatric and pregnant populations are needed to convince reluctant health authorities. More effective vaccines for younger children as well as improved availability of data regarding the optimal time period for vaccine administration in pregnant women appear relevant in this regard.

Original languageEnglish
Pages (from-to)5391-5396
JournalVaccine
Volume36
Issue number36
DOIs
Publication statusPublished - 2018

Fingerprint

Influenza Vaccines
influenza
vaccines
Vaccination
pregnant women
Vaccines
vaccination
Human Influenza
Pregnant Women
Herd Immunity
Pediatrics
Health
Population
Hospitalization
death
Viruses
viruses

Keywords

  • Children
  • Influenza
  • Influenza vaccine
  • Maternal immunization
  • Pregnancy

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Influenza vaccine use to protect healthy children : A debated topic. / Principi, Nicola; Esposito, Susanna.

In: Vaccine, Vol. 36, No. 36, 2018, p. 5391-5396.

Research output: Contribution to journalArticle

Principi, Nicola ; Esposito, Susanna. / Influenza vaccine use to protect healthy children : A debated topic. In: Vaccine. 2018 ; Vol. 36, No. 36. pp. 5391-5396.
@article{51a858af9b2b4f2baa99d355d9cafef9,
title = "Influenza vaccine use to protect healthy children: A debated topic",
abstract = "At the beginning of this century, a number of studies suggested that in healthy children, particularly those <2. years of age, influenza could have a serious and complicated course, as it frequently led to hospitalization and sometimes, albeit rarely, to death. Moreover, pre-schoolers and school-age children were found to be among the most important causes of influenza transmission to the community, as they shed the virus for a longer time than adults and had frequent contact with greater numbers of individuals through day-care and school. These findings led a number of health authorities to modify the official recommendations regarding the use of influenza vaccine in healthy children. Several factors seem to indicate that vaccination against influenza in healthy children of any age and in pregnant women could be effective in preventing the disease in the entire paediatric population and in providing herd immunity in adults and old people as well. The direct advantages of the vaccine seem greater in younger subjects, particularly those <2-3. years of age. Vaccination of older children is considered effective by most experts, but high vaccination coverage of these subjects has been difficult to attain. Similar difficulties have been identified for the vaccination of pregnant women. These challenges can be overcome, at least in part, by appropriate information and accurate evaluations of available data. In addition, further studies specifically designed to clarify unresolved problems regarding vaccine use in paediatric and pregnant populations are needed to convince reluctant health authorities. More effective vaccines for younger children as well as improved availability of data regarding the optimal time period for vaccine administration in pregnant women appear relevant in this regard.",
keywords = "Children, Influenza, Influenza vaccine, Maternal immunization, Pregnancy",
author = "Nicola Principi and Susanna Esposito",
year = "2018",
doi = "10.1016/j.vaccine.2017.09.016",
language = "English",
volume = "36",
pages = "5391--5396",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "36",

}

TY - JOUR

T1 - Influenza vaccine use to protect healthy children

T2 - A debated topic

AU - Principi, Nicola

AU - Esposito, Susanna

PY - 2018

Y1 - 2018

N2 - At the beginning of this century, a number of studies suggested that in healthy children, particularly those <2. years of age, influenza could have a serious and complicated course, as it frequently led to hospitalization and sometimes, albeit rarely, to death. Moreover, pre-schoolers and school-age children were found to be among the most important causes of influenza transmission to the community, as they shed the virus for a longer time than adults and had frequent contact with greater numbers of individuals through day-care and school. These findings led a number of health authorities to modify the official recommendations regarding the use of influenza vaccine in healthy children. Several factors seem to indicate that vaccination against influenza in healthy children of any age and in pregnant women could be effective in preventing the disease in the entire paediatric population and in providing herd immunity in adults and old people as well. The direct advantages of the vaccine seem greater in younger subjects, particularly those <2-3. years of age. Vaccination of older children is considered effective by most experts, but high vaccination coverage of these subjects has been difficult to attain. Similar difficulties have been identified for the vaccination of pregnant women. These challenges can be overcome, at least in part, by appropriate information and accurate evaluations of available data. In addition, further studies specifically designed to clarify unresolved problems regarding vaccine use in paediatric and pregnant populations are needed to convince reluctant health authorities. More effective vaccines for younger children as well as improved availability of data regarding the optimal time period for vaccine administration in pregnant women appear relevant in this regard.

AB - At the beginning of this century, a number of studies suggested that in healthy children, particularly those <2. years of age, influenza could have a serious and complicated course, as it frequently led to hospitalization and sometimes, albeit rarely, to death. Moreover, pre-schoolers and school-age children were found to be among the most important causes of influenza transmission to the community, as they shed the virus for a longer time than adults and had frequent contact with greater numbers of individuals through day-care and school. These findings led a number of health authorities to modify the official recommendations regarding the use of influenza vaccine in healthy children. Several factors seem to indicate that vaccination against influenza in healthy children of any age and in pregnant women could be effective in preventing the disease in the entire paediatric population and in providing herd immunity in adults and old people as well. The direct advantages of the vaccine seem greater in younger subjects, particularly those <2-3. years of age. Vaccination of older children is considered effective by most experts, but high vaccination coverage of these subjects has been difficult to attain. Similar difficulties have been identified for the vaccination of pregnant women. These challenges can be overcome, at least in part, by appropriate information and accurate evaluations of available data. In addition, further studies specifically designed to clarify unresolved problems regarding vaccine use in paediatric and pregnant populations are needed to convince reluctant health authorities. More effective vaccines for younger children as well as improved availability of data regarding the optimal time period for vaccine administration in pregnant women appear relevant in this regard.

KW - Children

KW - Influenza

KW - Influenza vaccine

KW - Maternal immunization

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85029493320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029493320&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2017.09.016

DO - 10.1016/j.vaccine.2017.09.016

M3 - Article

VL - 36

SP - 5391

EP - 5396

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 36

ER -